acquired
Stage
About
PregLem is a biopharmaceutical company focused on developing therapeutics for women’s reproductive health, notably programs targeting uterine fibroids and endometriosis.
Explore PregLem's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.